RxDoctor Payments Data

George Burns, MD

MOHS-Micrographic Surgery · Clearwater, FLNPI 1508858044

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,009 and has fallen 82.4% since, to $178 in 2025.

$2,693in general payments, 2019–2025

Across 106 payments — averaging $25.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$582
  • Sun Pharmaceutical Industries Inc.$390
  • AbbVie$256
  • Sanofi$235
  • Lilly USA, LLC$219
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$143
  • plus $868 from 20 others

What the payments were for

  • Food & beverage$2,693100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,693 in reported general payments places this provider in the 60th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$218,188
Medicare patients
401
Services billed
2,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab16$121,173
Triamcinolone Acetonide196$1,493
Metronidazole18$1,338
Clobetasol Propionate43$1,257
Betamethasone Valerate23$1,095
Fluorouracil15$937
Doxycycline Hyclate24$551
Clindamycin Phosphate18$549
Betamethasone Dipropionate17$526
Cephalexin42$355
Hydrocortisone14$204
Mupirocin23$136
Prednisone14$78

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →